BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22974654)

  • 1. A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction.
    Flynn A; Chen X; O'Connell E; O'Brien T
    Stem Cell Res Ther; 2012 Sep; 3(5):36. PubMed ID: 22974654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
    Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
    Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction.
    Sun Z; Xie Y; Lee RJ; Chen Y; Jin Q; Lv Q; Wang J; Yang Y; Li Y; Cai Y; Wang R; Han Z; Zhang L; Xie M
    Theranostics; 2020; 10(11):4967-4982. PubMed ID: 32308762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular repressor of E1A-stimulated gene overexpression in bone mesenchymal stem cells protects against rat myocardial infarction.
    Peng C; Pei H; Wei F; Tian X; Deng J; Yan C; Li Y; Sun M; Zhang J; Liu D; Rong J; Wang J; Gao E; Li S; Han Y
    Int J Cardiol; 2015 Mar; 183():232-41. PubMed ID: 25679992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow mesenchymal stem cells overexpressing GATA-4 improve cardiac function following myocardial infarction.
    He JG; Li HR; Li BB; Xie QL; Yan D; Wang XJ
    Perfusion; 2019 Nov; 34(8):696-704. PubMed ID: 31090492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model.
    Rasmussen JG; Frøbert O; Holst-Hansen C; Kastrup J; Baandrup U; Zachar V; Fink T; Simonsen U
    Cell Transplant; 2014 Feb; 23(2):195-206. PubMed ID: 23211469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of high bioactivity multilayered bone-marrow mesenchymal stem cell sheets for myocardial infarction using a 3D-dynamic system.
    Wang Y; Zhang J; Qin Z; Fan Z; Lu C; Chen B; Zhao J; Li X; Xiao F; Lin X; Wu Z
    Acta Biomater; 2018 May; 72():182-195. PubMed ID: 29627677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats.
    Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ
    Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.
    Blondiaux E; Pidial L; Autret G; Rahmi G; Balvay D; Audureau E; Wilhelm C; Guerin CL; Bruneval P; Silvestre JS; Menasché P; Clément O
    J Tissue Eng Regen Med; 2017 Dec; 11(12):3417-3427. PubMed ID: 28156084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.
    Makkar RR; Price MJ; Lill M; Frantzen M; Takizawa K; Kleisli T; Zheng J; Kar S; McClelan R; Miyamota T; Bick-Forrester J; Fishbein MC; Shah PK; Forrester JS; Sharifi B; Chen PS; Qayyum M
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):225-33. PubMed ID: 16382259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
    Sim WS; Park BW; Ban K; Park HJ
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.
    Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT
    J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone promotes activation of resident cardiac stem cells by transplanted mesenchymal stem cells in a rat myocardial infarction model.
    Zhang GW; Gu TX; Sun XJ; Wang C; Qi X; Wang XB; Li-Ling J
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):570-82. PubMed ID: 27056755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.